Skip to main content

Featured

Lebanon Seeks to Distance State from Hezbollah After Cyprus Drone Incident

                                                         File photo: Youssef Ragg Lebanon has urged Cypriot authorities and the public not to conflate the Lebanese state with Hezbollah following a drone strike that originated from Lebanese territory and hit Cyprus six days earlier. Lebanese Foreign Minister Youssef Raggi emphasized that the attack was carried out independently by Hezbollah and does not reflect the policies, values, or intentions of the Lebanese government.  Raggi stressed that Lebanon rejects any attempt to use its territory for external agendas and reiterated that Hezbollah’s actions fall outside the state’s legal authority. He called on Cyprus to distinguish between the official Lebanese government and groups operating autonomously, noting that Lebanon has consistently affirmed its sovereignty ...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment